Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

The University of Kansas Cancer Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

The University of Kansas Cancer Center brings 8 presentations to ASH 2026 in New Orleans. Its research centres on lymphoma, leukemia and transplant outcomes. Work covers golcadomide with Pola-R-CHP, TP53 changes in mantle cell lymphoma and engineered gamma-delta T cells after transplant.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
NCI-designated comprehensive cancer center of the University of Kansas, serving the Kansas City region.
Symposium
Fri Dec 11
7:00pm–10:00pm
Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know
Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research.
Lymphoma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The University of Kansas Cancer Center

Tell us what you sell and we’ll find the people at The University of Kansas Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction